The optimal time of B-type natriuretic peptide sampling associated with post-myocardial infarction remodelling after primary percutaneous coronary intervention

Cardiovascular Journal of Africa

Volumn 24, Issue 5, 2013, Pages 165-170

  Choi, Hyunmin ^a   Yoo, Byung Su ^c,d   Doh, Joon Hyung ^b   Yoon, Hee Jeong ^a   Ahn, Min Soo ^c,d   Kim, Jang Young ^c,d   Lee, Seung Hwan ^c,d   Yoon, Junghan ^c,d  

^a Gumdan Top Hospital   (South Korea)

^b Inje University College of Medicine   (South Korea)

^c Wonju Severance Christian Hospital   (South Korea)

^d Yonsei University Wonju College of Medicine   (South Korea)

Author keywords

B type natriuretic peptide; Myocardial infarction; Remodelling

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART INFARCTION; HEMODYNAMICS; HOSPITAL ADMISSION; HUMAN; MALE; PERCUTANEOUS CORONARY INTERVENTION; POST MYOCARDIAL INFARCTION REMODELLING; PROTEIN BLOOD LEVEL; REVASCULARIZATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

AGED; CLINICAL PROTOCOLS; ECHOCARDIOGRAPHY, DOPPLER; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84883359360     PISSN: 19951892     EISSN: None     Source Type: Journal    
DOI: 10.5830/CVJA-2013-024     Document Type: Article

References (26)

1. Tapanainen JM, Lindgren KS, Makikallio TH, Vuolteenaho O, Leppaluoto J, Huikuri HV. Natriuretic peptides as predictors of non-sudden and sudden cardiac death after acute myocardial infarction in the beta-blocking era. J Am Coll Cardiol 2004; 43: 757-763 (14998613).
2. Savoye C, Equine O, Tricot O, Nugue O, Segrestin B, Sautiere K, et al. Left ventricular remodeling after anterior wall acute myocardial infarction in modern clinical practice (from the REmodelage VEntriculaire [REVE] study group). Am J Cardiol 2006; 98: 1144-1149 (17056315).
3. Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002; 347: 161-167 (12124404).
4. Ahn MS, Yoo BS. Two problems with analyzing natriuretic Peptide levels: obesity and acute myocardial infarction. Korean Circ J 2010; 40: 550-551 (21217930).
5. Garcia-Alvarez A, Sitges M, Delgado V, Ortiz J, Vidal B, Poyatos S, et al. Relation of plasma brain natriuretic peptide levels on admission for ST-elevation myocardial infarction to left ventricular end-diastolic volume six months later measured by both echocardiography and cardiac magnetic resonance. Am J Cardiol 2009; 104: 878-882 (19766750).
6. Katayama T, Nakashima H, Yonekura T, Honda Y, Suzuki S, Yano K. Clinical significance of acute-phase brain natriuretic peptide in acute myocardial infarction treated with direct coronary angioplasty. J Cardiol 2003; 42: 195-200 (14658407).
7. Hirayama A, Kusuoka H, Yamamoto H, Sakata Y, Asakura M, Higuchi Y, et al. Serial changes in plasma brain natriuretic peptide concentration at the infarct and non-infarct sites in patients with left ventricular remodelling after myocardial infarction. Heart 2005; 91: 1573-1577 (15774610).
8. Hirayama A, Kusuoka H, Yamamoto H, Sakata Y, Asakura M, Higuchi Y, et al. Usefulness of plasma brain natriuretic peptide concentration for predicting subsequent left ventricular remodeling after coronary angioplasty in patients with acute myocardial infarction. Am J Cardiol 2006; 98: 453-457 (16893696).
9. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2: 358-367 (2698218).
10. Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quinones MA. Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 1997; 30: 1527-1533 (9362412).
11. Mega JL, Morrow DA, De Lemos JA, Sabatine MS, Murphy SA, Rifai N, et al. B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRETIMI- 23 substudy. J Am Coll Cardiol 2004; 44: 335-339 (15261928).
12. Vorlat A, Claeys MJ, Bosmans JM, Van Hoof V, Vrints CJ. B-type natriuretic peptide and assessment of jeopardised myocardium in acute myocardial infarction. Int J Cardiol 2007; 114: 46-49 (16644042).
13. Richards AM, Nicholls MG, Yandle TG, Frampton C, Espiner EA, Turner JG, et al. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation 1998; 97: 1921-1929 (9609085).
14. Richards AM, Nicholls MG, Yandle TG, Ikram H, Espiner EA, Turner JG, et al. Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction. The Christchurch Cardioendocrine Research Group. Heart 1999; 81: 114-120 (9922344).
15. Crilley JG, Farrer M. Left ventricular remodelling and brain natriuretic peptide after first myocardial infarction. Heart 2001; 86: 638-642 (11711456).
16. Bassan R, Potsch A, Maisel A, Tura B, Villacorta H, Nogueira MV, et al. B-type natriuretic peptide: a novel early blood marker of acute myocardial infarction in patients with chest pain and no ST-segment elevation. Eur Heart J 2005; 26: 234-240 (15618053).
17. Dengler TJ, Gleissner CA, Klingenberg R, Sack FU, Schnabel PA, Katus HA. Biomarkers after heart transplantation: nongenomic. Heart Fail Clin 2007; 3: 69-81 (17545010).
18. Menger MD, Vollmar B. Pathomechanisms of ischemia-reperfusion injury as the basis for novel preventive strategies: is it time for the introduction of pleiotropic compounds? Transplant Proc 2007; 39: 485-488 (17362764).
19. Jaffe R, Dick A, Strauss BH. Prevention and treatment of microvascular obstruction related myocardial injury and coronary no-reflow following percutaneous coronary intervention: a systematic approach. JACC Cardiovasc Interv 2010; 3: 695-704 (20650430).
20. Bruder O, Jensen C, Jochims M, Farazandeh M, Barkhausen J, Schlosser T, et al. Relation of B-type natriuretic peptide (BNP) and infarct size as assessed by contrast-enhanced MRI. Int J Cardiol 2010; 144: 53-58 (19410308).
21. Roubille F, Samri A, Cornillet L, Sportouch-Dukhan C, Davy JM, Raczka F, et al. Routinely-feasible multiple biomarkers score to predict prognosis after revascularized STEMI. Eur J Intern Med 2010; 21: 131-136 (20206886).
22. Suzuki E, Hirata Y, Kohmoto O, Sugimoto T, Hayakawa H, Matsuoka H, et al. Cellular mechanisms for synthesis and secretion of atrial natriuretic peptide and brain natriuretic peptide in cultured rat atrial cells. Circ Res 1992; 71: 1039-1048 (1394868).
23. Richards AM, Nicholls MG, Espiner EA, Lainchbury JG, Troughton RW, Elliott J, et al. B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction. Circulation 2003; 107: 2786-2792 (12771003).
24. Morita E, Yasue H, Yoshimura M, Ogawa H, Jougasaki M, Matsumura T, et al. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation 1993; 88: 82-91 (8319360).
25. Hillis GS, Ujino K, Mulvagh SL, Hagen ME, Oh JK. Echocardiographic indices of increased left ventricular filling pressure and dilation after acute myocardial infarction. J Am Soc Echocardiogr 2006; 19: 450-456 (16581486).
26. Temporelli PL, Giannuzzi P, Nicolosi GL, Latini R, Franzosi MG, Gentile F, et al. Doppler-derived mitral deceleration time as a strong prognostic marker of left ventricular remodeling and survival after acute myocardial infarction: results of the GISSI-3 echo substudy. J Am Coll Cardiol 2004; 43: 1646-1653 (15120826).